Showing results (1-10 of 337) with videos related to
Sort By:
Pageof 34
Gynecologic Oncology|December 1, 1989
Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study)W T Creasman, S Gall, B N Bundy, et al.Gynecologic Oncology|January 1, 1986
Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H D Homesley, et al.Cancer|May 1, 1986
A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group StudyG Omura, J A Blessing, C E Ehrlich, et al.American Journal of Obstetrics and Gynecology|February 18, 1998
Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group studyW T Creasman, R J Zaino, F J Major, et al.Cancer|October 15, 1987
Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group StudyW T Creasman, C P Morrow, B N Bundy, et al.Gynecologic Oncology|February 1, 1990
Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group StudyC P Morrow, B N Bundy, H D Homesley, et al.Gynecologic Oncology|January 1, 1991
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group studyC P Morrow, B N Bundy, R J Kurman, et al.American Journal of Obstetrics and Gynecology|April 1, 1994
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaW J Hoskins, W P McGuire, M F Brady, et al.Women'S Health (London, England)|December 24, 2010
The current status of lymphadenectomy in the management of endometrial cancerW T CreasmanJournal of Women'S Health|February 4, 1999
Is there an association between hormone replacement therapy and breast cancer?W T CreasmanPageof 34